{"issuance_frequency":"","notes_translated":{"fr":"Le Relevé des maladies transmissibles au Canada est une publication bilingue et libre d'accès revue par un comité de lecture portant sur la prévention et le contrôle des maladies infectieuses nouvelles et tenaces\r\n","en":"The Canada Communicable Disease Report is a bilingual, open-access, peer-reviewed journal on the prevention and control of emerging and persistent infectious diseases. \r\n"},"issn":"","imso_approval":"true","isbn":"","creator":"","org_section":{"fr":"","en":""},"jurisdiction":"federal","private":false,"maintainer_email":"open-ouvert@tbs-sct.gc.ca","num_tags":0,"edition":"","frequency":"unknown","data_series_issue_identification":{"fr":"","en":""},"contributor":{"fr":"","en":""},"maintainer":null,"ready_to_publish":"true","id":"6ff2c83c-291b-4d44-8d33-6b995d164f2d","metadata_created":"2019-02-05T23:43:48.402742","subject":["health_and_safety"],"pspc_identification_number":"","metadata_modified":"2019-02-05T23:43:48.402750","author":null,"author_email":null,"geographic_region":[],"portal_release_date":"2019-02-05","digital_object_identifier":"","state":"active","version":null,"keywords":{"fr":["l'écosystème microbien","bactéries en tant que médicaments","antimicrobiens","L'immunisation","résistance aux antimicrobiens","Instituts de recherche","Innovation et résistance aux antimicrobiens","résistance aux antimicrobiens"],"en":["bugs as drugs","microbial ecosystem therapeutics","antimicrobial resistance","immunization and antimicrobial resistance","Canadian Institutes of Health Research","antimicrobial resistance","innovation and antimicrobial resistance","Clinical Microbiology and Infectious Diseases","Microbial Epidemiological Markers","Navigating Microbial Genomes","Association of Medical Microbiology and Infectious Disease Canada","AMMI","Medical Microbiology and Infectious Disease","Infectious Disease"]},"relationships_as_object":[],"creator_user_id":"4cfa9a9c-1d95-40eb-86f9-bc0c8ec45d1f","title_translated":{"fr":"RMTC : Volume 41S-5, le 19 novembre 2015 : Résistance aux antimicrobiens et innovation","en":"CCDR: Volume 41S-5, November 19, 2015: Antimicrobial resistance and innovation"},"type":"info","resources":[{"cache_last_updated":null,"unique_identifier":"","package_id":"6ff2c83c-291b-4d44-8d33-6b995d164f2d","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"39fea38d-9403-45bc-a979-a404fecf8436","related_relationship":"","name_translated":{"fr":"RMTC : Volume 41S-5, le 19 novembre 2015 : Résistance aux antimicrobiens et innovation","en":"CCDR: Volume 41S-5, November 19, 2015: Antimicrobial resistance and innovation"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"CCDR: Volume 41S-5, November 19, 2015: Antimicrobial resistance and innovation","language":["en"],"created":"2019-02-05T23:43:49.038264","url":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2015-41/ccdr-volume-41s-5-november-19-2015.html","last_modified":null,"position":0,"revision_id":"234191ca-86fe-4fe8-9211-f4d441f22c49","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"6ff2c83c-291b-4d44-8d33-6b995d164f2d","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"8855e80e-d5b1-47d2-b53f-a7f798a0859b","related_relationship":"","name_translated":{"fr":"RMTC : Volume 41S-5, le 19 novembre 2015 : Résistance aux antimicrobiens et innovation","en":"CCDR: Volume 41S-5, November 19, 2015: Antimicrobial resistance and innovation"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"CCDR: Volume 41S-5, November 19, 2015: Antimicrobial resistance and innovation","language":["fr"],"created":"2019-02-05T23:43:49.038273","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2015-41/rmtc-volume-41s-5-19-novembre-2015.html","last_modified":null,"position":1,"revision_id":"234191ca-86fe-4fe8-9211-f4d441f22c49","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"6ff2c83c-291b-4d44-8d33-6b995d164f2d","datastore_active":false,"id":"3a00ef57-ff50-48ab-9a49-30b5b698e398","character_set":"","state":"active","name_translated":{"fr":"RMTC : Volume 41S-5, le 19 novembre 2015 : Résistance aux antimicrobiens et innovation","en":"CCDR: Volume 41S-5, November 19, 2015: Antimicrobial resistance and innovation"},"hash":"","description":"","format":"PDF","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"CCDR: Volume 41S-5, November 19, 2015: Antimicrobial resistance and innovation","language":["en"],"created":"2019-02-05T23:43:49.038276","url":"https://www.canada.ca/content/dam/phac-aspc/migration/phac-aspc/publicat/ccdr-rmtc/15vol41/dr-rm41s-5/assets/pdf/15vol41s-5-eng.pdf","last_modified":null,"position":2,"revision_id":"234191ca-86fe-4fe8-9211-f4d441f22c49","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"6ff2c83c-291b-4d44-8d33-6b995d164f2d","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"ef3ed428-f2c9-46d1-9ddf-5abf25978135","related_relationship":"","name_translated":{"fr":"RMTC : Volume 41S-5, le 19 novembre 2015 : Résistance aux antimicrobiens et innovation","en":"CCDR: Volume 41S-5, November 19, 2015: Antimicrobial resistance and innovation"},"hash":"","description":"","format":"PDF","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"CCDR: Volume 41S-5, November 19, 2015: Antimicrobial resistance and innovation","language":["fr"],"created":"2019-02-05T23:43:49.038278","url":"https://www.canada.ca/content/dam/phac-aspc/migration/phac-aspc/publicat/ccdr-rmtc/15vol41/dr-rm41s-5/assets/pdf/15vol41s-5-fra.pdf","last_modified":null,"position":3,"revision_id":"234191ca-86fe-4fe8-9211-f4d441f22c49","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"6ff2c83c-291b-4d44-8d33-6b995d164f2d","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"5de91e72-d0ec-4676-a24b-af0c32eb7c24","related_relationship":"","name_translated":{"fr":"Recours à des bactéries en tant que médicaments : traitement de l'écosystème microbien","en":"Using bugs as drugs: Microbial ecosystem therapeutics"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Using bugs as drugs: Microbial ecosystem therapeutics","language":["en"],"created":"2019-02-05T23:43:49.038281","url":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2015-41/ccdr-volume-41s-5-november-19-2015/ccdr-volume-41s-5-november-19-2015-1.html","last_modified":null,"position":4,"revision_id":"234191ca-86fe-4fe8-9211-f4d441f22c49","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"6ff2c83c-291b-4d44-8d33-6b995d164f2d","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"13512a9a-f1d6-411f-b7cf-8c7ed63c9281","related_relationship":"","name_translated":{"fr":"Recours à des bactéries en tant que médicaments : traitement de l'écosystème microbien","en":"Using bugs as drugs: Microbial ecosystem therapeutics"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Using bugs as drugs: Microbial ecosystem therapeutics","language":["fr"],"created":"2019-02-05T23:43:49.038283","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2015-41/rmtc-volume-41s-5-19-novembre-2015/rmtc-volume-41s-5-19-novembre-2015-1.html","last_modified":null,"position":5,"revision_id":"234191ca-86fe-4fe8-9211-f4d441f22c49","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"6ff2c83c-291b-4d44-8d33-6b995d164f2d","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"fb313e00-afc6-4f2e-a38a-aee9a4a9ad6d","related_relationship":"","name_translated":{"fr":"L'immunisation comme outil pour lutter contre la résistance aux antimicrobiens","en":"Immunization as a tool to combat antimicrobial resistance"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Immunization as a tool to combat antimicrobial resistance","language":["en"],"created":"2019-02-05T23:43:49.038285","url":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2015-41/ccdr-volume-41s-5-november-19-2015/ccdr-volume-41s-5-november-19-2015.html","last_modified":null,"position":6,"revision_id":"234191ca-86fe-4fe8-9211-f4d441f22c49","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"6ff2c83c-291b-4d44-8d33-6b995d164f2d","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"cb20e89c-24e7-406c-8054-ad556cec36c2","related_relationship":"","name_translated":{"fr":"L'immunisation comme outil pour lutter contre la résistance aux antimicrobiens","en":"Immunization as a tool to combat antimicrobial resistance"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Immunization as a tool to combat antimicrobial resistance","language":["fr"],"created":"2019-02-05T23:43:49.038288","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2015-41/rmtc-volume-41s-5-19-novembre-2015/rmtc-volume-41s-5-19-novembre-2015.html","last_modified":null,"position":7,"revision_id":"234191ca-86fe-4fe8-9211-f4d441f22c49","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"6ff2c83c-291b-4d44-8d33-6b995d164f2d","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"f0af56ff-31a1-4b8f-b80a-0a156bae3e56","related_relationship":"","name_translated":{"fr":"Réponse des Instituts de recherche en santé du Canada à l'égard de la résistance aux antimicrobiens","en":"The Canadian Institutes of Health Research response to antimicrobial resistance"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"The Canadian Institutes of Health Research response to antimicrobial resistance","language":["en"],"created":"2019-02-05T23:43:49.038290","url":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2015-41/ccdr-volume-41s-5-november-19-2015/ccdr-volume-41s-5-november-19-2015-3.html","last_modified":null,"position":8,"revision_id":"234191ca-86fe-4fe8-9211-f4d441f22c49","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"6ff2c83c-291b-4d44-8d33-6b995d164f2d","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"a70fd194-54ae-4893-9284-aa8e26eac1f4","related_relationship":"","name_translated":{"fr":"Réponse des Instituts de recherche en santé du Canada à l'égard de la résistance aux antimicrobiens","en":"The Canadian Institutes of Health Research response to antimicrobial resistance"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"The Canadian Institutes of Health Research response to antimicrobial resistance","language":["fr"],"created":"2019-02-05T23:43:49.038292","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2015-41/rmtc-volume-41s-5-19-novembre-2015/rmtc-volume-41s-5-19-novembre-2015-3.html","last_modified":null,"position":9,"revision_id":"234191ca-86fe-4fe8-9211-f4d441f22c49","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"6ff2c83c-291b-4d44-8d33-6b995d164f2d","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"49a6c416-a095-4e8b-bc28-c1b9ad82008b","related_relationship":"","name_translated":{"fr":"Innovation et résistance aux antimicrobiens","en":"Innovation and antimicrobial resistance"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Innovation and antimicrobial resistance","language":["en"],"created":"2019-02-05T23:43:49.038295","url":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2015-41/ccdr-volume-41s-5-november-19-2015/ccdr-volume-41s-5-november-19-2015-2.html","last_modified":null,"position":10,"revision_id":"234191ca-86fe-4fe8-9211-f4d441f22c49","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"6ff2c83c-291b-4d44-8d33-6b995d164f2d","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"6e2329c1-69df-4907-a08f-0d9c4d5d6771","related_relationship":"","name_translated":{"fr":"Innovation et résistance aux antimicrobiens","en":"Innovation and antimicrobial resistance"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Innovation and antimicrobial resistance","language":["fr"],"created":"2019-02-05T23:43:49.038297","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2015-41/rmtc-volume-41s-5-19-novembre-2015/rmtc-volume-41s-5-19-novembre-2015-2.html","last_modified":null,"position":11,"revision_id":"234191ca-86fe-4fe8-9211-f4d441f22c49","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"6ff2c83c-291b-4d44-8d33-6b995d164f2d","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"e73d883b-665e-4a2f-b18f-e654cc971584","related_relationship":"","name_translated":{"fr":" European Society of Clinical Microbiology and Infectious Diseases (ESCMID). International Meeting on Microbial Epidemiological Markers. Navigating Microbial Genomes: Insights from the Next Generation. Estoril, Portugal","en":"European Society of Clinical Microbiology and Infectious Diseases (ESCMID). International Meeting on Microbial Epidemiological Markers. Navigating Microbial Genomes: Insights from the Next Generation. Estoril, Portugal"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"European Society of Clinical Microbiology and Infectious Diseases (ESCMID). International Meeting on Microbial Epidemiological Markers. Navigating Microbial Genomes: Insights from the Next Generation. Estoril, Portugal","language":["en"],"created":"2019-02-05T23:43:49.038299","url":"https://www.escmid.org/research_projects/escmid_conferences/immem_xi/","last_modified":null,"position":12,"revision_id":"234191ca-86fe-4fe8-9211-f4d441f22c49","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"6ff2c83c-291b-4d44-8d33-6b995d164f2d","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"56a1c024-779e-412e-8245-63bf1044fbbc","related_relationship":"","name_translated":{"fr":" European Society of Clinical Microbiology and Infectious Diseases (ESCMID). International Meeting on Microbial Epidemiological Markers. Navigating Microbial Genomes: Insights from the Next Generation. Estoril, Portugal","en":"European Society of Clinical Microbiology and Infectious Diseases (ESCMID). International Meeting on Microbial Epidemiological Markers. Navigating Microbial Genomes: Insights from the Next Generation. Estoril, Portugal"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"European Society of Clinical Microbiology and Infectious Diseases (ESCMID). International Meeting on Microbial Epidemiological Markers. Navigating Microbial Genomes: Insights from the Next Generation. Estoril, Portugal","language":["fr"],"created":"2019-02-05T23:43:49.038302","url":"https://www.escmid.org/research_projects/escmid_conferences/immem_xi/","last_modified":null,"position":13,"revision_id":"234191ca-86fe-4fe8-9211-f4d441f22c49","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"6ff2c83c-291b-4d44-8d33-6b995d164f2d","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"1d78f7e6-c321-41c3-9249-83e9bad698d8","related_relationship":"","name_translated":{"fr":"NA","en":"Association of Medical Microbiology and Infectious Disease Canada - AMMI Annual Conference. Vancouver, British Columbia"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Association of Medical Microbiology and Infectious Disease Canada - AMMI Annual Conference. Vancouver, British Columbia","language":["en"],"created":"2019-02-05T23:43:49.038304","url":"https://www.ammi.ca/annual-conference/","last_modified":null,"position":14,"revision_id":"234191ca-86fe-4fe8-9211-f4d441f22c49","resource_type":"website"}],"place_of_publication":[],"num_resources":15,"tags":[],"spatial":"","collection":"publication","org_title_at_publication":{"fr":"Agence de la santé publique du Canada","en":"Public Health Agency of Canada"},"date_published":"2015-11-19 00:00:00","issuance":"","groups":[],"license_id":"ca-ogl-lgo","data_series_name":{"fr":"","en":""},"relationships_as_subject":[],"license_title":"Open Government Licence - Canada","restrictions":"unrestricted","organization":{"description":"","created":"2016-09-23T17:25:57.068700","title":"Public Health Agency of Canada | Agence de la santé publique du Canada","name":"phac-aspc","is_organization":true,"state":"active","image_url":"","revision_id":"96161da6-edc7-4d1d-99e0-baac9df7b3b9","type":"organization","id":"1C71053B-AA64-4646-956B-41631C396018","approval_status":"approved"},"name":"6ff2c83c-291b-4d44-8d33-6b995d164f2d","isopen":false,"additional_notes":{"fr":"","en":""},"departmental_identification_number":"","notes":"The Canada Communicable Disease Report is a bilingual, open-access, peer-reviewed journal on the prevention and control of emerging and persistent infectious diseases. \r\n","owner_org":"1C71053B-AA64-4646-956B-41631C396018","program_page_url":{"fr":"","en":""},"url":null,"audience":[],"gc_catalogue_number":"","license_url":"http://open.canada.ca/en/open-government-licence-canada","series_publication_dates":{"fr":"","en":""},"title":"CCDR: Volume 41S-5, November 19, 2015: Antimicrobial resistance and innovation","revision_id":"234191ca-86fe-4fe8-9211-f4d441f22c49"}